Cancer immunotherapy
Types of monoclonal antibodies
Columns: Antibody | Brand name | Approval date | Type | Target | Approved treatment(s)
Alemtuzumab | Campath | 2001 | humanized | CD52 | Chronic lymphocytic leukemia | Bevacizumab | Avastin | 2004 | humanized | vascular endothelial growth factor | colorectal cancer | Brentuximab vedotin | Adcetris | 2011 | chimeric | CD30 | Hodgkin lymphoma , Anaplastic large-cell lymphoma | Cetuximab | Erbitux | 2004 | chimeric | epidermal growth factor receptor | colorectal cancer | Gemtuzumab ozogamicin | Mylotarg | 2000 | humanized | CD33 | acute myelogenous leukemia (with calicheamicin ) | Panitumumab | Vectibix | 2006 | human | epidermal growth factor receptor | colorectal cancer | Rituximab | Rituxan, Mabthera | 1997 | chimeric | CD20 | non-Hodgkin lymphoma